These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28829250)

  • 1. Form vs Function, fighting the last war: a reflection on the exchange between Larrabee, Bianchini, Boone, and Rohling (2017) and Nichols (2017) over Nichols and Gass (2015). The Fake Bad Scale (FBS): malingering or ligation response syndrome - Which is it?
    Arbisi PA
    Clin Neuropsychol; 2017 Nov; 31(8):1406-1411. PubMed ID: 28829250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fake bad scale: the case of the missing construct, a response to Larrabee, Bianchini, Boone, and Rohling (2017).
    Nichols DS
    Clin Neuropsychol; 2017 Nov; 31(8):1396-1400. PubMed ID: 28866953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MMPI-2/MMPI-2-RF Symptom Validity Scale (FBS/FBS-r) is not a measure of 'litigation response syndrome': commentary on Nichols and Gass (2015).
    Larrabee GJ; Bianchini KJ; Boone KB; Rohling ML
    Clin Neuropsychol; 2017 Nov; 31(8):1387-1395. PubMed ID: 28829224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity of the MMPI-2/MMPI-2-RF Symptom Validity Scale (FBS/FBS-r) is established: reply to Nichols (2017).
    Larrabee GJ; Bianchini KJ; Boone KB; Rohling ML
    Clin Neuropsychol; 2017 Nov; 31(8):1401-1405. PubMed ID: 28994350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The construct validity of the Lees-Haley Fake Bad Scale. Does this scale measure somatic malingering and feigned emotional distress?
    Butcher JN; Arbisi PA; Atlis MM; McNulty JL
    Arch Clin Neuropsychol; 2003 Jul; 18(5):473-85. PubMed ID: 14591444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minnesota Multiphasic Personality Inventory-2 revised form Symptom Validity Scale-Revised (MMPI-2-RF FBS-r; also known as Fake Bad Scale): psychometric characteristics in a nonlitigation neuropsychological setting.
    Gass CS; Odland AP
    J Clin Exp Neuropsychol; 2012; 34(6):561-70. PubMed ID: 22384793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMPI-2 Symptom Validity (FBS) Scale: psychometric characteristics and limitations in a Veterans Affairs neuropsychological setting.
    Gass CS; Odland AP
    Appl Neuropsychol Adult; 2014; 21(1):1-8. PubMed ID: 24826489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
    Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
    Sellbom M; Wygant D; Bagby M
    Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MMPI-2 Fake Bad Scale: concordance and specificity of true and estimated scores.
    Nelson NW; Parsons TD; Grote CL; Smith CA; Sisung JR
    J Clin Exp Neuropsychol; 2006 Jan; 28(1):1-12. PubMed ID: 16448972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutoff Scores for MMPI-2 and MMPI-2-RF Cognitive-Somatic Validity Scales for Psychometrically Defined Malingering Groups in a Military Sample.
    Jones A
    Arch Clin Neuropsychol; 2016 Nov; 31(7):786-801. PubMed ID: 27405640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Fake Bad Scale and other MMPI-2 validity scales with personal injury litigants.
    Tsushima WT; Tsushima VG
    Assessment; 2001 Jun; 8(2):205-12. PubMed ID: 11428699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Lees-Haley Fake Bad Scale, Henry-Heilbronner Index, and restructured clinical scale 1 in identifying noncredible symptom reporting.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C; Stanczak SR
    Clin Neuropsychol; 2008 Sep; 22(5):919-29. PubMed ID: 18756392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a Response Bias Scale (RBS) for the MMPI-2.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Assessment; 2007 Jun; 14(2):196-208. PubMed ID: 17504891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the relationship between the reconstructed scales and the fake bad scale of the MMPI-2.
    Downing SK; Denney RL; Spray BJ; Houston CM; Halfaker DA
    Clin Neuropsychol; 2008 Jul; 22(4):680-8. PubMed ID: 18597202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MMPI-2 Symptom Validity Scale (FBS) not influenced by medical impairment: a large sleep center investigation.
    Greiffenstein MF
    Assessment; 2010 Jun; 17(2):269-77. PubMed ID: 20124428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the new MMPI-2 Malingered Depression scale to individuals undergoing neuropsychological evaluation: relative lack of relationship to secondary gain and failure on validity indices.
    Sweet JJ; Malina A; Ecklund-Johnson E
    Clin Neuropsychol; 2006 Sep; 20(3):541-51. PubMed ID: 16895865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Henry-Heilbronner Index: a 15-item empirically derived MMPI-2 subscale for identifying probable malingering in personal injury litigants and disability claimants.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C
    Clin Neuropsychol; 2006 Dec; 20(4):786-97. PubMed ID: 16980262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.